Bessemer Group
ANIP icon

Bessemer Group’s ANI Pharmaceuticals ANIP Stock Holding History

Bessemer Group’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.79M Hold
57,909
– – 0.01% 589
2026
Q1 		$4.45M Buy
57,909
+19,800
+52% +$1.55M 0.01% 522
2025
Q4 		$3.01M Buy
38,109
+37,928
+20,955% +$3.28M ﹤0.01% 710
2025
Q3 		$17K Buy
181
+55
+44% +$4.49K ﹤0.01% 1749
2025
Q2 		$8K Buy
126
+116
+1,160% +$7.55K ﹤0.01% 1878
2025
Q1 		$1K Sell
10
-81
-89% -$4.84K ﹤0.01% 2302
2024
Q4 		$5K Hold
91
– – ﹤0.01% 1982
2024
Q3 		$6K Buy
91
+24
+36% +$1.46K ﹤0.01% 1825
2024
Q2 		$4K Hold
67
– – ﹤0.01% 1728
2024
Q1 		$5K Buy
+67
New +$4.04K ﹤0.01% 1690
2020
Q3 		– Sell
-26,700
Closed -$863K – 1348
2020
Q2 		$863K Hold
26,700
– – ﹤0.01% 843
2020
Q1 		$1.09M Buy
26,700
+4,400
+20% +$234K ﹤0.01% 589
2019
Q4 		$1.38M Sell
22,300
-1,500
-6% -$99.4K ﹤0.01% 675
2019
Q3 		$1.74M Buy
23,800
+800
+3% +$59.9K 0.01% 553
2019
Q2 		$1.89M Buy
23,000
+2,354
+11% +$167K 0.01% 550
2019
Q1 		$1.46M Buy
20,646
+3,446
+20% +$203K 0.01% 546
2018
Q4 		$774K Buy
17,200
+14,764
+606% +$774K ﹤0.01% 639
2018
Q3 		$138K Buy
+2,436
New +$149K ﹤0.01% 1057

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bessemer Group's ANIP Position: Q2 2026 in Review

Bessemer Group held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 57,909 shares worth $4.79M. The position accounts for 0.01% of the portfolio, ranked #589.

Bessemer Group first reported a position in ANIP in Q3 2018 and has held it in 18 quarters since. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Bessemer Group held 57,909 shares of ANI Pharmaceuticals worth $4.79M as of Q2 2026.
  • Bessemer Group left its ANI Pharmaceuticals share count unchanged in Q2 2026.
  • ANI Pharmaceuticals made up 0.01% of Bessemer Group's portfolio in Q2 2026, its #589 holding.
  • Bessemer Group first reported a position in ANI Pharmaceuticals in Q3 2018 and has held it in 18 quarters since.
  • 308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.